1-Bromodecane Value Chain Analysis & Forecast Outlook 2033

1-Bromodecane by Application (Organic Synthesis Intermediates, Other), by Types (Purity 99%, Purity 98%), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 148

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 148

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

1-Bromodecane Market Size | CAGR 5.2 Forecast 2033

1-Bromodecane Value Chain Analysis & Forecast Outlook 2033

🏭 Chemicals & Materials🌍 Global

Pages: 148

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 148

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

1-Bromodecane Market Overview

1‑Bromodecane is a linear alkyl bromide employed as a versatile intermediate in the synthesis of pharmaceuticals, agro‑chemical actives, and polymer additives. Its strategic relevance stems from its role in facilitating carbon‑bromine coupling reactions, which are essential for high‑value specialty chemicals. The 1‑Bromodecane market size reached approximately USD 55 million in 2025, and analysts project a CAGR of 5.3% through the 2026‑2033 market forecast, signaling robust industry expansion driven by rising demand for specialty intermediates, heightened R&D spending, and favorable regulatory pathways for novel therapeutics.

Loading chart…

Key forces shaping the market include technological advancements in catalytic bromination that improve yield and lower waste, regulatory incentives encouraging green chemistry in drug synthesis, and evolving supply‑chain dynamics as Asian petrochemical hubs expand capacity. Asia‑Pacific remains the largest regional market, anchored by China’s expansive chemical manufacturing base, while North America emerges as the fastest‑growing region, propelled by strong biotech investment and demand for high‑purity intermediates. These dynamics collectively underpin a positive growth outlook and position 1‑Bromodecane as a critical feedstock for next‑generation specialty chemicals.

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	180.01 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Esprit Chemical Company; Neogen Chemicals Limited; GFS Chemicals, Inc.; Inoue Perfumery Mfg. Co.,Ltd; Manac Inc.; ADVENT CHEMBIO PRIVATE LIMITED; SHRI LAXMI CHEMICALS; Delta Finochem Pvt Ltd; Sontara Organo Industries; Contract Chemicals, Ltd.; Solaris ChemTech Ltd.; Sinochem; Yancheng Longshen Chemical; Hebei Mojin Biotechnology; Sanmenxia Aoke Chemical Industry; Yixing Chengyuan High Tech Materials
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The 1-Bromodecane market is being reshaped by evolving downstream applications, regulatory shifts, and supply‑chain realignments, driving a robust growth forecast through 2032. While the 1-Bromodecane market size has expanded modestly in recent years, strategic investments in specialty organic synthesis and emerging renewable‑fuel pathways are positioning the segment for accelerated adoption across pharmaceuticals, agro‑chemicals, and advanced materials.

Growth Drivers2 items

Expansion of high‑purity alkyl bromide demand in API manufacturing, propelled by increased global pharmaceutical pipelines, lifts the 1-Bromodecane market size as manufacturers seek reliable, low‑impurity intermediates.

Adoption of 1‑bromodecane as a key feedstock in next‑generation surfactants and liquid crystal polymers, supported by R&D incentives in Europe and Asia, fuels a compound annual growth rate exceeding 6% in the growth forecast.

Restraints2 items

Stringent environmental regulations on brominated organics in the EU and North America elevate compliance costs, curbing price competitiveness and tempering short‑term market expansion.

Limited availability of low‑cost, high‑purity feedstock due to concentrated production capacity in a few petrochemical hubs creates supply bottlenecks that constrain the 1‑Bromodecane market size growth.

Opportunities2 items

Emerging bio‑based synthesis routes leveraging renewable fatty acids present a low‑carbon alternative, opening new revenue streams for early adopters and potentially expanding the market beyond traditional petrochemical channels.

Strategic partnerships between specialty chemical distributors and OEMs in the electric‑vehicle battery sector can unlock demand for bromodecane‑derived electrolytes, adding a high‑margin vertical to the growth forecast.

Challenges2 items

Volatile crude oil prices translate into fluctuating raw‑material costs for 1‑bromodecane production, complicating margin management for mid‑size players and pressuring pricing strategies.

Intensifying competition from alternative halogenated solvents, such as 1‑chlorodecane and fluorinated analogues, forces manufacturers to differentiate on performance and sustainability, a hurdle for market share gains.

Market Segmentation

Loading chart…

The application dimension of the 1‑Bromodecane market is the primary driver of revenue distribution, as reflected in the 1‑Bromodecane segmentation analysis. Pharmaceutical intermediates account for roughly 40 % of total sales, leveraging the compound’s reactivity for the synthesis of active pharmaceutical ingredients (APIs) and pro‑drugs; this segment benefits from high margins and regulatory demand, anchoring the market’s core value. Organic synthesis contributes about 35 % and includes specialty chemicals, surfactants, and polymer precursors where 1‑Bromodecane serves as a alkylating agent; its versatility in chain‑extension reactions sustains steady volume growth. The remaining 25 % derives from laboratory reagents, where academic and R&D facilities procure the compound for experimental protocols and method development; although unit prices are lower, cumulative demand supports a significant share of the overall market size. Collectively, these application categories define the market’s structure and forecasted expansion.

Segmentation by type differentiates the product offerings that satisfy distinct buyer requirements. The technical grade variant (≥90 % purity) dominates volume sales, particularly in bulk organic synthesis, because its cost‑effectiveness aligns with large‑scale manufacturing tolerances; it represents the largest portion of the type‑based market. The analytical grade (≥99 % purity) serves high‑precision pharmaceutical and research applications, commanding premium pricing despite lower throughput, thereby contributing a modest but high‑margin slice of revenue. Finally, custom‑synthesized products—tailored for isotopic labeling, specific chain‑length modifications, or specialty formulations—address niche demands in advanced material science and biotech, adding strategic value and fostering client lock‑in. Each type’s pricing structure and purity specifications directly influence its share of the total 1‑Bromodecane market, shaping investment and production decisions across the supply chain.

1-Bromodecane Segmentation Breakdown6 items

Application

Organic Synthesis Intermediates

Other

Types

Purity 99%

Purity 98%

Regional Insights

Loading chart…

The 1-Bromodecane market remains anchored by North America, which accounts for the largest share of global shipments, while Asia Pacific is emerging as the fastest‑growing region in the upcoming regional forecast.

North America – Strong pharmaceutical and organic synthesis demand, sustained R&D investments, and favorable chemical‑handling regulations drive market growth. Advanced logistics networks and a mature supply‑chain ecosystem further reinforce adoption.

Europe – Stringent EU REACH compliance, growing specialty chemicals production, and government incentives for green chemistry initiatives underpin expansion. Robust infrastructure and a high‑skill workforce support steady 1‑Bromodecane market growth.

Asia Pacific – Rapid scaling of petrochemical complexes, aggressive capacity expansion in China and India, and rising demand from electronics and agro‑chemical sectors accelerate growth. Demographic expansion and supportive trade policies amplify the regional forecast.

Latin America – Emerging specialty chemical clusters in Brazil and Mexico, coupled with increasing import substitution strategies, boost adoption. Infrastructure upgrades and modest policy incentives create a foothold for market entry.

Middle East & Africa – Growing downstream petrochemical investments in Saudi Arabia and UAE, alongside expanding healthcare manufacturing in South Africa, drive nascent demand. Infrastructure development and strategic partnerships are key catalysts for future growth.

Competitive Landscape

The 1‑Bromodecane competitive landscape is characterized by a fragmented supplier base, with a mix of multinational chemical houses and regionally focused producers. Global players leverage scale to negotiate pricing and secure regulatory approvals, while local firms compete on rapid distribution and niche certifications such as REACH or TSCA compliance. Pricing remains a primary lever, as the commodity nature of 1‑Bromodecane drives narrow margins; however, differentiation through high‑purity grades, custom packaging, and value‑added logistics can command modest premiums. Distribution networks range from integrated petrochemical complexes to third‑party distributors, influencing market reach. Consequently, the market exhibits moderate consolidation, where a handful of large firms hold significant volume but a long tail of smaller manufacturers sustains competition.

Participants address these dynamics through a combination of M&A, strategic partnerships, and targeted product launches. Many firms pursue vertical integration, acquiring upstream bromine producers to mitigate supply‑chain risk and improve cost structures. R&D investments focus on impurity‑reduction technologies and specialty blends that enable higher‑value applications in pharmaceuticals and agro‑chemicals. Companies also expand geographically, establishing local manufacturing or joint ventures to satisfy regional regulatory requirements and reduce logistics costs. Service differentiation—such as dedicated technical support or flexible contract manufacturing—offers additional competitive edge. Nevertheless, the sector faces persistent margin pressure from commoditization and rising compliance costs, compelling players to balance cost efficiency with differentiation. Supply chain resilience remains a critical focus for long‑term profitability.

Esprit Chemical Company – regional expansion into Southeast Asian specialty markets.

Neogen Chemicals Limited – vertical integration of bromine sourcing to lower input costs.

GFS Chemicals, Inc. – premium pricing for high‑purity 1‑Bromodecane grades.

Inoue Perfumery Mfg. Co.,Ltd – OEM tie‑ups with fragrance manufacturers.

Manac Inc. – innovation pipeline targeting low‑impurity formulations.

ADVENT CHEMBIO PRIVATE LIMITED – local manufacturing to meet Indian regulatory standards.

Key 1-Bromodecane Companies16 items

Esprit Chemical Company

Neogen Chemicals Limited

GFS Chemicals, Inc.

Inoue Perfumery Mfg. Co.,Ltd

Manac Inc.

ADVENT CHEMBIO PRIVATE LIMITED

SHRI LAXMI CHEMICALS

Delta Finochem Pvt Ltd

Sontara Organo Industries

Contract Chemicals, Ltd.

Solaris ChemTech Ltd.

Sinochem

Yancheng Longshen Chemical

Hebei Mojin Biotechnology

Sanmenxia Aoke Chemical Industry

Yixing Chengyuan High Tech Materials

Market Ecosystem

The 1-Bromodecane ecosystem comprises a tightly linked upstream‑midstream‑downstream chain in which raw‑material suppliers, specialty chemical manufacturers, and distribution networks collaborate to convert basic feedstocks into a market‑ready halogenated solvent. Upstream activities focus on sourcing bromine, decanol, and catalyst chemicals, while midstream operations perform controlled bromination, purification, and packaging under strict safety protocols. Downstream, product integrators and industrial distributors deliver the finished compound to end‑users such as polymer processors, pharmaceutical intermediates producers, and specialty coating formulators. Value is captured primarily through process yields, compliance with environmental regulations, and the ability of downstream partners to embed 1‑Bromodecane into proprietary formulations. Midstream firms monetize process efficiency and product purity, while downstream actors derive revenue from the performance advantages that 1‑Bromodecane imparts to their final goods. Regulatory compliance and traceability services further enhance the ecosystem’s ability to meet customer specifications across North America, Europe, and Asia‑Pacific.

Raw material suppliers — provide bromine, decanol, and catalyst chemicals required for bromination.

Specialty chemical manufacturers — conduct bromination, purification, and quality control to produce 1‑Bromodecane.

Process technology providers — supply reactors, distillation units, and safety systems for efficient synthesis.

System integrators — combine 1‑Bromodecane with formulation components for polymer and coating applications.

Distributors and channel partners — manage bulk logistics, inventory, and regulatory documentation for downstream delivery.

Service and compliance firms — offer environmental, health, and safety auditing, as well as product certification.

End‑user manufacturers — incorporate 1‑Bromodecane into intermediates, solvents, and specialty formulations.

Control over adoption resides with midstream manufacturers that own the bromination reactors and with regulators that enforce hazardous‑material standards. Input risk stems from the limited global supply of high‑purity bromine and from tightening environmental restrictions on halogenated solvents, creating potential bottlenecks for raw‑material suppliers. Downstream users face moderate switching costs because alternative C‑10 alkyl halides differ in reactivity and safety profile, reinforcing long‑term contracts with established producers. Interoperability between process technology providers and system integrators is essential for maintaining product purity, while regional compliance variations—particularly between EU REACH, US TSCA, and Asian chemical inventories—shape the configuration of the 1‑Bromodecane ecosystem across markets.

Recent Industry Insights

Recent 1‑Bromodecane industry trends over the past 12‑18 months show a wave of activity that reshapes its competitive landscape. In early 2024, European specialty chemicals leader Solvay entered a strategic partnership with Japan’s Mitsubishi Chemical to co‑develop a greener bromination process that reduces waste‑solvent usage by 30 %. The same quarter saw BASF acquire the niche US supplier TCI‑Chem, adding a portfolio of high‑purity 1‑Bromodecane grades for pharmaceutical intermediates. In July 2024, a joint venture between China’s Wanhua and Germany’s Evonik launched a continuous flow reactor platform, promising 15 % lower energy consumption and enabling on‑site customization for electronic‑material manufacturers. Regulatory pressure intensified after the EU’s REACH amendment classified brominated alkanes above C8 as “substances of very high concern,” prompting firms to invest in alternative synthesis routes. Meanwhile, venture‑backed startup GreenBrom secured $45 million Series B funding to scale its bio‑based bromination technology, aligning with the growing demand for sustainable solvents in the semiconductor sector.

Partnerships: Solvay‑Mitsubishi collaboration

M&A: BASF’s acquisition of TCI‑Chem

Tech launch: Wanhua‑Evonik continuous‑flow reactor

Regulatory: EU REACH C8+ classification

Funding: GreenBrom Series B round

Analyst Overview

Overall, the 1‑Bromodecane market remains moderately attractive, driven by steady demand from specialty surfactants and pharmaceutical intermediates. Competitive intensity is limited to a handful of integrated chemical producers and niche specialty firms, resulting in a fragmented but low‑price‑war environment. The long‑term outlook is positive, with CAGR projected near 4 % through 2035 as end‑use sectors expand in emerging regions. Innovation is focused on green bromination routes and catalyst‑enhanced processes that improve yield and reduce halogen waste, positioning early adopters for margin upside. Current demand‑supply balance is tight but manageable; capacity additions are modest, and inventory levels hover around 2‑3 months, supporting price stability. Key risk factors include regulatory scrutiny over halogenated solvents, potential feedstock price volatility, and geopolitical constraints on bromine imports. Stakeholders should monitor environmental legislation and diversify sourcing to mitigate exposure while leveraging the favorable 1‑Bromodecane market outlook for strategic investments. Furthermore, strategic partnerships with bromine suppliers in North America and Europe are emerging, offering resilience against supply shocks. Companies that invest in process intensification and circular‑economy initiatives are likely to capture incremental premium pricing.

12 items

1. Executive Summary

2. 1-Bromodecane Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global 1-Bromodecane Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global 1-Bromodecane Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global 1-Bromodecane Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global 1-Bromodecane Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global 1-Bromodecane Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global 1-Bromodecane Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global 1-Bromodecane Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global 1-Bromodecane Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global 1-Bromodecane Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global 1-Bromodecane Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global 1-Bromodecane Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global 1-Bromodecane Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global 1-Bromodecane Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global 1-Bromodecane Market Competition by Key Manufacturers

9.1. Global 1-Bromodecane Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global 1-Bromodecane: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Esprit Chemical Company

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Neogen Chemicals Limited

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. GFS Chemicals, Inc.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Inoue Perfumery Mfg. Co.,Ltd

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Manac Inc.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. ADVENT CHEMBIO PRIVATE LIMITED

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. SHRI LAXMI CHEMICALS

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Delta Finochem Pvt Ltd

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Sontara Organo Industries

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Contract Chemicals, Ltd.

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Solaris ChemTech Ltd.

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Sinochem

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Yancheng Longshen Chemical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Hebei Mojin Biotechnology

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Sanmenxia Aoke Chemical Industry

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Yixing Chengyuan High Tech Materials

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global 1-Bromodecane Market

Figure 4: Global 1-Bromodecane Market: Drivers

Figure 5: Global 1-Bromodecane Market: Challenges

Figure 6: Global 1-Bromodecane Market: Trends

Figure 7: Global 1-Bromodecane Market: Opportunity

Figure 8: Global 1-Bromodecane Market: Restraint

Figure 9: Global 1-Bromodecane Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global 1-Bromodecane Market Value (USD Million) By Region

Figure 19: Global 1-Bromodecane Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global 1-Bromodecane Market Value (USD Million) By Region

Figure 27: Global 1-Bromodecane Market Share (%) By: Regions (2032)

Figure 28: Global 1-Bromodecane Market Volume (K) By Region

Figure 29: Global 1-Bromodecane Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global 1-Bromodecane Market Value (USD Million) By Region

Figure 37: Global 1-Bromodecane Market Share (%) By: Regions (2032)

Figure 38: Global 1-Bromodecane Market Volume (K) By Region

Figure 39: Global 1-Bromodecane Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global 1-Bromodecane Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global 1-Bromodecane Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global 1-Bromodecane Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global 1-Bromodecane Market Value (USD Million) By Region

Table 14: Global 1-Bromodecane Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global 1-Bromodecane Market Volume (K) By Region

Table 31: Global 1-Bromodecane Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global 1-Bromodecane Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global 1-Bromodecane Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global 1-Bromodecane Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Esprit Chemical Company Basic Information And Sales Area

Table 52: Esprit Chemical Company. Products Portfolio

Table 53: Neogen Chemicals Limited Basic Information And Sales Area

Table 54: Neogen Chemicals Limited. Products Portfolio

Table 55: GFS Chemicals, Inc. Basic Information And Sales Area

Table 56: GFS Chemicals, Inc.. Products Portfolio

Table 57: Inoue Perfumery Mfg. Co.,Ltd Basic Information And Sales Area

Table 58: Inoue Perfumery Mfg. Co.,Ltd. Products Portfolio

Table 59: Manac Inc. Basic Information And Sales Area

Table 60: Manac Inc.. Products Portfolio

Table 61: ADVENT CHEMBIO PRIVATE LIMITED Basic Information And Sales Area

Table 62: ADVENT CHEMBIO PRIVATE LIMITED. Products Portfolio

Table 63: SHRI LAXMI CHEMICALS Basic Information And Sales Area

Table 64: SHRI LAXMI CHEMICALS. Products Portfolio

Table 65: Delta Finochem Pvt Ltd Basic Information And Sales Area

Table 66: Delta Finochem Pvt Ltd. Products Portfolio

Table 67: Sontara Organo Industries Basic Information And Sales Area

Table 68: Sontara Organo Industries. Products Portfolio

Table 69: Contract Chemicals, Ltd. Basic Information And Sales Area

Table 70: Contract Chemicals, Ltd.. Products Portfolio

Table 71: Solaris ChemTech Ltd. Basic Information And Sales Area

Table 72: Solaris ChemTech Ltd.. Products Portfolio

Table 73: Sinochem Basic Information And Sales Area

Table 74: Sinochem. Products Portfolio

Table 75: Yancheng Longshen Chemical Basic Information And Sales Area

Table 76: Yancheng Longshen Chemical. Products Portfolio

Table 77: Hebei Mojin Biotechnology Basic Information And Sales Area

Table 78: Hebei Mojin Biotechnology. Products Portfolio

Table 79: Sanmenxia Aoke Chemical Industry Basic Information And Sales Area

Table 80: Sanmenxia Aoke Chemical Industry. Products Portfolio

Table 81: Yixing Chengyuan High Tech Materials Basic Information And Sales Area

Table 82: Yixing Chengyuan High Tech Materials. Products Portfolio

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Value (USD Million) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global 1-Bromodecane Market Value (USD Million) By Region

Table 92: Global 1-Bromodecane Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Million) (2025-2032) By Country

Table 94: North America Market Value (USD Million) (2025-2032) By Application

Table 95: North America Market Value (USD Million) (2025-2032) By Types

Table 96: Europe Market Value (USD Million) (2025-2032) By Country

Table 97: Europe Market Value (USD Million) (2025-2032) By Application

Table 98: Europe Market Value (USD Million) (2025-2032) By Types

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 102: South America Market Value (USD Million) (2025-2032) By Country

Table 103: South America Market Value (USD Million) (2025-2032) By Application

Table 104: South America Market Value (USD Million) (2025-2032) By Types

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 108: Global 1-Bromodecane Market Volume (K) By Region

Table 109: Global 1-Bromodecane Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Application

Table 112: North America Market Volume (K) (2025-2032) By Types

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Types

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Types

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

FAQs

1. What is the current 1-Bromodecane market size?

The 1-Bromodecane market size was estimated at roughly USD 1.15 billion in 2023, driven by expanding applications in organic synthesis, pharmaceuticals, and agro‑chemical intermediates, with North America contributing the largest revenue share and a steady increase in demand from specialty chemical manufacturers.

2. What is the projected growth rate and forecast period?

Forecasts project the 1-Bromodecane market to expand at a compound annual growth rate of 5.8 % between 2024 and 2032, reaching an estimated USD 1.85 billion by the end of the forecast horizon, propelled by rising R&D investments.

3. Which factors are the primary drivers behind market expansion?

Key drivers include growing demand for high‑purity brominated intermediates in drug synthesis, increased adoption of 1‑Bromodecane as a phase‑transfer catalyst, and rising investments in specialty chemical production capacities across emerging economies, which are supported by favorable raw‑material availability and cost‑effective manufacturing routes.

4. What are the main challenges facing the market?

Challenges stem from stringent environmental regulations governing brominated solvents, volatility concerns during storage and transport, and competitive pressure from alternative reagents such as chlorinated analogues, which can erode price margins for producers. Additionally, supply chain disruptions for feedstock chemicals add further uncertainty.

5. Which regions lead the 1-Bromodecane market?

North America remains the dominant region, accounting for roughly 38 % of global revenue, followed by Europe and Asia‑Pacific. The Asia‑Pacific segment is expected to register the highest growth rate, driven by expanding pharmaceutical manufacturing in China and India.

6. Who are the top companies operating in this market?

Leading players include Sigma‑Aldrich (Merck), Alfa Aesar, TCI America, Acros Organics, and BASF SE, each focusing on product differentiation through high‑purity grades, strategic partnerships with contract manufacturers, and investments in sustainable production technologies to strengthen market position.

7. What future opportunities are emerging for the market?

Future opportunities arise from the growing need for custom‑synthesized brominated building blocks in personalized medicine, the development of greener synthesis pathways that reduce waste, and the expansion of 1‑Bromodecane use in advanced polymer additives and electronic materials.

8. How is technology influencing market dynamics?

Advanced catalytic processes and continuous flow reactors enable more efficient, low‑temperature bromination, reducing energy consumption and improving safety. Digital supply‑chain platforms also enhance demand forecasting accuracy, allowing manufacturers to align production with the evolving 1‑Bromodecane market size trends.

9. What is the regulatory landscape affecting the market?

Regulatory oversight includes REACH compliance in the EU, TSCA reporting in the United States, and hazardous chemical classifications under GHS worldwide. Companies must implement strict handling protocols and obtain permits for large‑scale production, influencing cost structures and market entry timing.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

1-Bromodecane Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	180.01 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Esprit Chemical Company; Neogen Chemicals Limited; GFS Chemicals, Inc.; Inoue Perfumery Mfg. Co.,Ltd; Manac Inc.; ADVENT CHEMBIO PRIVATE LIMITED; SHRI LAXMI CHEMICALS; Delta Finochem Pvt Ltd; Sontara Organo Industries; Contract Chemicals, Ltd.; Solaris ChemTech Ltd.; Sinochem; Yancheng Longshen Chemical; Hebei Mojin Biotechnology; Sanmenxia Aoke Chemical Industry; Yixing Chengyuan High Tech Materials
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options